A severe case of buruli ulcer disease with pleural effusions. by Sarfo, FS et al.
Symposium
A Severe Case of Buruli Ulcer Disease with Pleural
Effusions
Fred S. Sarfo1,2*, William Thompson3, Richard O. Phillips1,2, Albert Paintsil4, Mohammed K. Abass3,
Michael Frimpong5, Justice Abotsi3, Kingsley Asiedu6, Mark H. Wansbrough-Jones7
1 Komfo Anokye Teaching Hospital, Kumasi, Ghana, 2 School of Medical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana, 3Agogo
Presbyterian Hospital, Ministry of Health, Agogo, Ghana, 4 Korle-Bu Teaching Hospital, Accra, Ghana, 5 Kumasi Center for Collaborative Research, Kumasi, Ghana, 6World
Health Organisation, Geneva, Switzerland, 7 St. George’s University of London, London, United Kingdom
Presentation of Case
Patient GO is an 8-year-old student
from Drobonso, a Buruli ulcer–endemic
community in the Sekyere Afram Plains
of the Ashanti region of Ghana. She
presented with a month’s history of a
painless nodule on the anterior chest
which started increasing in size rapidly
over the course of two weeks. After
applying herbal preparations on the lesion
and observing no improvement in symp-
toms, she sought medical attention
through which a course of oral amoxycil-
lin was prescribed for a week. However,
her lesion continued to enlarge with
involvement of her anterior and posterior
chest walls and ulcerations over the left
anterior cervical triangle and midsternal
region. Upon the recommendation of a
former patient from the same endemic
region, she came to the Buruli ulcer clinic
at the Agogo Presbyterian Hospital on the
24th of February 2011. On examination,
the patient looked fairly stable and was
afebrile (36.9uC), not pale, and anicteric
with no regional lymphadenopathy. Her
chest was clinically clear with a respira-
tory rate of 14 cycles/min. The most
significant finding was an extensive oe-
dematous lesion involving the chest and
neck regions with two deep ulcerations
(Figure 1). She weighed 31 kg at diagnosis
(95th centile in weight for age). Swab
samples obtained from the ulcer were
positive by PCR for IS2404, acid-alcohol-
fast bacilli, and Mycobacterium ulcerans
culture on Lowenstein-Jensen culture
slopes. Patient was admitted, and antibi-
otic combination therapy comprising
daily intramuscular injection of 15 mg/
kg of streptomycin and 10 mg/kg of oral
rifampin was started together with wound
care and nutritional support.
Two weeks into treatment, she was
noted to have become breathless with the
accompaniment of fever and chills but
with no associated cough. Clinical exam-
inations revealed the presence of pleural
effusions bilaterally and pyrexia of
37.9uC. Full blood counts revealed her
white cell count had increased from 10.3
x 103/L on admission to 20.8 x 103/L.
An HIV antibody test was negative, and
the performance of a chest X-ray con-
firmed the presence of bilateral pleural
effusions (Figure 2). Diagnostic pleural
aspirate showed the effusion to be an
exudate with an elevated protein con-
centration of 82.5 g/l, pH= 7.5, and
predominantly neutrophils on cytopa-
thology but no isolates on aerobic and
anaerobic cultures. PCR on pleural
aspirate was positive for M. ulcerans but
was negative for tuberculosis—a differ-
ential diagnosis. An aspirate of the
effusion was tested for the presence of
mycolactone using UPLC-mass spec-
trometry, as described elsewhere [1],
but the intact mycolactone A/B was
not detected. The left pleural effusion
was drained with the aid of a chest tube
and by needle aspiration of the right
pleural effusion. She was put on 30 mg
of oral prednisone twice daily for 2 weeks
with resolution of the effusion within 2
weeks of its appearance. However, the
effusion on the right side recurred
(Figure 2D) and was managed success-
fully by needle thoracocentesis. Upon
completion of antimycobacterial antibi-
otic therapy for 8 weeks, surgery was
performed, comprising excision and skin
grafting. The lesion healed gradually
over 48 weeks but resulted in a hyper-
trophic scar over the manubrio-sternum.
Parental informed consent was obtained.
Case Discussion
This case report is instructive in
illustrating the successes and challenges
associated with Buruli ulcer management
in rural communities in endemic coun-
tries and in highlighting a rare presenta-
tion of paradoxical reaction of M. ulcerans
disease. Combination antibiotic therapy
comprising daily oral rifampin and
intramuscular streptomycin for 8 weeks
has demonstrated excellent efficacy in
healing all forms and categories of M.
ulcerans disease, with surgery sometimes
necessary in large category III lesions
(lesions .15 cm at its widest diameter)
[2]. However, antibiotic therapy for M.
ulcerans disease may be associated with
paradoxical exacerbations or with the
appearance of secondary lesions at dif-
ferent sites, often referred to as a
paradoxical reaction [3–6].
Paradoxical reaction or exacerbation
of mycobacterial infections during anti-
biotic therapy is a well-characterised
phenomenon, and in M. ulcerans disease
a few case reports have been published
[3–6]. However, to the best of our
knowledge, this is the first description
of pleural effusion in association with
antibiotic-treatment-associated para-
doxical reaction in M. ulcerans disease.
In M. ulcerans disease, paradoxical reac-
tions often are characterised by the
occurrence of inflammatory pus-filled
lesions either close to the primary site of
the lesion or sometimes at secondary
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sites distant from the primary lesions.
These lesions either occur during or
some weeks after completion of antibi-
otic therapy. The phenomenon, akin to
the immune reconstitution inflammato-
ry syndrome amongst HIV patients on
antiretroviral therapy, is thought to be
due to an exuberant reconstitution of
the local immune response during the
demise of M. ulcerans bacilli under the
influence of antibiotic therapy and
mediated by immunostimulators [7]
released from dying mycobacteria in a
milieu of declining mycolactone con-
centrations. This is evidenced histolog-
ically by massive leucocyte infiltrations
of necrotic areas in surgically excised
paradoxical lesions in contrast to the
acellular to scanty immune cell infil-
trates observed in untreated M. ulcerans–
infected skin lesions.
Although M. ulcerans causes a pre-
dominantly cutaneous infection, it may
occasionally involve deeper structures
such as the bone, causing osteomyelitis.
Mycolactone has been shown to be
cytotoxic to a range of immune and
nonimmune cells [8]. It is possible that
the manifestation of bilateral pleural
effusions in this patient who had an
extensive oedematous lesion on the
chest wall may signify a local destruc-
tion and extension through the chest-
wall muscles into the pleural cavities.
Against this proposition is the absence
of clinically or radiologically demon-
strable pneumothoraces. The most
probable explanation, however, is that
M. ulcerans might have been carried into
the pleural cavity via the lymphatics to
elicit a vigorous inflammatory response
once mycolactone concentrations began
to decline under the influence of antibi-
otic therapy. In murine studies, M.
ulcerans is found to be present in local
and regional lymph nodes at some stage
during infection [9].
This patient improved on supportive
therapy comprising thoracocentesis, a 2-
week course of prednisone, completion of
the 8-week course of antibiotics, nutrition-
al support, and surgical therapy including
debridement and skin grafting, with her
lesions healing without recurrence.
Figure 1. An extensive category III oedematous lesion involving the anterior and posterior chest and neck regions, with two ulcers:
one at the anterior triangle of the neck, measuring 6 cm x 8 cm, and another over the midsternal region of the chest, measuring
3 cm x 4 cm.
doi:10.1371/journal.pntd.0002868.g001
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Figure 2. Chest radiographs of patient before and during antibiotic chemotherapy for M. ulcerans disease. (A) Chest X-ray taken before
antibiotic therapy was started. (B) Chest X-ray taken 2 weeks after initiation of antibiotic therapy, showing bilateral pleural effusions. (C) Week 3 after
drainage of pleural effusion. (D) Recurrence of pleural effusion on the right hemithorax at week 4.
doi:10.1371/journal.pntd.0002868.g002
Key Learning Points
N M. ulcerans disease of the chest wall may rarely be associated with exudative
pleural effusions.
N M. ulcerans cultures of pleural aspirates were negative, which is typical of
paradoxical reactions.
N Management of pleural effusions due to paradoxical reactions should include
thoracocentesis, steroid therapy, and management of ulcers along conventional
lines.
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